Jakko van Ingen

66PUBLICATIONS
93CO-AUTHORS
Medical virologyMedical infection agents (incl. prions)Medical mycologyMedical bacteriologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Oct 01, 2026
Inflammation Precedes Paradoxical Reactions in HIV-Negative Patients With Pulmonary Tuberculosis.

|Sep 30, 2026
Amikacin Liposome Inhalation Suspension in Newly Diagnosed Mycobacterium avium Complex Lung Disease: A Phase 3b, Double-blind, Randomized Clinical Trial (ENCORE).

|Jul 30, 2026
Pharmacokinetics of minocycline with and without rifampicin co-administration in patients with nontuberculous mycobacterial disease.

|Jun 13, 2026
Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease.

|May 25, 2026
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.

|Mar 31, 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.

Charles L Daley, Jakko van Ingen, James D Chalmers

Pageof 11

Frequent Collaborators

11 joint publications

Wouter Hoefsloot

8 joint publications

Mike Marvin Ruth

7 joint publications

Ralf Stemkens

6 joint publications

Dirk Wagner